EurekAlert! -
7 Jun 2021 06:00
(Cactus Communications) Vaccines are critical tools for fighting COVID-19, and new vaccines will expand overall vaccine availability. In an article recently published in Chinese Medical Journal, a research team use phase 1 and 2 clinical trial data to show that a vaccine called KCONVAC, which contains an inactivated virus, is safe and can stimulate antibody production. These findings support the initiation of a phase 3 trial to confirm that the vaccine is safe and effective.
Share this Article